Hait William's Form 4 filing
Johnson & Johnson (JNJ) · filed Oct 26, 2022
- Accession no.
- 0001225208-22-011139
- Filed
- Oct 26, 2022
- Trade date
- Oct 24, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.57M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hait WilliamCIK 0001904791 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 | Common Stock | MOption exerciseAcquired | +15,000 | $90.44 | +$1,356,600 | 95,236 | Direct | |
| Oct 24, 2022 | Common Stock | SSaleDisposed | −1,187 | $171.55 | −$203,629.85 | 94,049 | Direct | |
| Oct 24, 2022 | Common Stock | SSaleDisposed | −13,813 | $171.55 | −$2,369,620.15 | 80,236 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00F1 | $0 | 14,698 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $171.52 to $171.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table II.
Remarks
Title: Chief External Innovation and Medical Safety Officer